NCT00953147 · Interventional trial
A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older
Overall registry status Completed
Phase 3
Conditions Allergic Rhinitis, Perennial Allergic Rhinitis
Delaware Valley sites
- Asthma and Allergy Research Associates · Upland, PA · Delaware County
First posted
Registry updated
Added to the directory